Cognition Therapeutics, Inc. (CGTX)
1.19
-0.05
(-4.03%)
USD |
NASDAQ |
May 27, 16:00
1.18
-0.01
(-0.84%)
After-Hours: 19:49
Cognition Therapeutics Free Cash Flow : -20.25M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Verrica Pharmaceuticals, Inc. | -14.22M |
| Corcept Therapeutics, Inc. | 119.79M |
| Assertio Holdings, Inc. | -7.081M |
| Johnson & Johnson | 17.80B |
| Eli Lilly & Co. | 10.37B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.542M |
| Cash from Financing (Quarterly) | -0.233M |
| Free Cash Flow Per Share (Quarterly) | -0.0621 |
| Free Cash Flow to Equity (Quarterly) | -5.369M |
| Free Cash Flow to Firm (Quarterly) | -5.537M |
| Free Cash Flow Yield | -21.29% |